Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection

Utility of a Clinical Risk Factor Scoring Model in Predicting Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae on Hospital Admission

(2013) Steven W. Johnson et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection

(2012) Meltem Isikgoz Tasbakan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria

(2012) L. S. Briongos-Figuero et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

(2012) Wouter C. Rottier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology and genetic characteristics of extended-spectrum  -lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities

(2012) M. Tinelli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System

(2011) Mario Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009–2010

(2011) Daryl J. Hoban et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy

(2011) S. Meier et al.   INFECTION

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy

(2010) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact

(2010) Jesús Oteo et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Defining an extended-spectrum β-lactamase

(2008) D.M. Livermore   CLINICAL MICROBIOLOGY AND INFECTION